LILLIAN DEVITO: Open Payments
NPI 1336599091 · DEERFIELD BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 17 payments from 7 companies in 2025. Trend: 2023 $304 · 2024 $305 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| GENZYME CORPORATION | 4 | $95 |
| Janssen Biotech, Inc. | 2 | $49 |
| Genentech USA, Inc. | 1 | $33 |
| PFIZER INC. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: VENCLEXTA, Fabhalta, SARCLISA, PLUVICTO, ELAHERE, Tecentriq Hybreza, TECVAYLI, IBRANCE.
Industry payments across FL — which companies pay providers there.
